IMC Chicago’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Sell
71,100
-6,100
-8% -$297K ﹤0.01% 2379
2026
Q1
$3.31M Sell
77,200
-5,400
-7% -$232K ﹤0.01% 2146
2025
Q4
$3.62M Buy
82,600
+25,200
+44% +$1.04M ﹤0.01% 1967
2025
Q3
$2.37M Buy
57,400
+10,600
+23% +$426K ﹤0.01% 2102
2025
Q2
$2.06M Buy
46,800
+8,000
+21% +$320K ﹤0.01% 1982
2025
Q1
$1.43M Buy
+38,800
New +$1.38M ﹤0.01% 2024
2024
Q1
Sell
-10,800
Closed -$259K 2390
2023
Q4
$259K Buy
+10,800
New +$235K ﹤0.01% 1763

Other funds holding EXEL

IMC Chicago's EXEL Position: Q2 2026 in Review

IMC Chicago sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 9,170 shares — an estimated $446K sold.

IMC Chicago first reported a position in EXEL in Q4 2023 and held it in 2 quarters. The position peaked at $393K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • IMC Chicago reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 9,170 Exelixis shares in Q2 2026, an estimated $446K.
  • IMC Chicago first reported a position in Exelixis in Q4 2023 and held it in 2 quarters.
  • IMC Chicago's Exelixis position peaked at $393K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.